Mutational analysis of splicing machinery genesSF3B1, U2AF1andSRSF2in myelodysplasia and other common tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mutational analysis of splicing machinery genesSF3B1, U2AF1andSRSF2in myelodysplasia and other common tumors

Published:2013-02-05 Issue:1 Volume:133 Page:260-265
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Je Eun Mi¹,Yoo Nam Jin,Kim Yoo Jin²,Kim Myung Shin³,Lee Sug Hyung

Affiliation:

1. Department of Pathology, College of Medicine; The Catholic University of Korea; Seoul; 137-701; Korea

2. Department of Internal Medicine, College of Medicine; The Catholic University of Korea; Seoul; 137-701; Korea

3. Department of Laboratory Medicine, College of Medicine; The Catholic University of Korea; Seoul; 137-701; Korea

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Myelodysplastic syndromes;Tefferi;N Engl J Med,2009

2. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos;Tefferi;Cancer,2009

3. Frequent pathway mutations of splicing machinery in myelodysplasia;Yoshida;Nature,2011

4. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts;Papaemmanuil;N Engl J Med,2011

5. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes;Graubert;Nat Genet,2011

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review);Oncology Reports;2023-11-16

2. Mutant SF3B1 promotes malignancy in PDAC;eLife;2023-10-12

3. Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer;Current Topics in Medicinal Chemistry;2023-08

4. SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process;Frontiers in Oncology;2023-03-17

5. Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia;Experimental Hematology & Oncology;2022-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3